TAK
Takeda Pharmaceutical
Halal Rating :
See Details
Last Price
$14.97
Last updated:
Market Cap
$48.2b
7D Change
-6.23%
1 Year Change
14.67%
Company Overview
Industries
Exchange
NYSE
Next Earnings Date
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $1.06t | $568.93b | $33.54b | $59.58b | 3.17% | 10.47% |
| March 31, 2023 | $956.16b | $557.82b | $40.65b | $42.93b | 4.25% | 7.70% |
| Dec. 31, 2022 | $1.1t | $613.59b | $41.68b | $79.75b | 3.80% | 13.00% |
Company Impact
Help us evaluate Takeda Pharmaceutical's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.